Susquehanna International Group
DPLO

Susquehanna International Group’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Susquehanna International Group’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-28,870
Closed -$115K – 11333
2019
Q4 		$115K Sell
28,870
-107,578
-79% -$505K ﹤0.01% 9080
2019
Q3 		$669K Buy
136,448
+48,712
+56% +$273K ﹤0.01% 6624
2019
Q2 		$534K Buy
+87,736
New +$466K ﹤0.01% 7127
2017
Q1 		– Sell
-70,567
Closed -$1.02M – 10481
2016
Q4 		$889K Buy
+70,567
New +$1.31M ﹤0.01% 5782
2016
Q2 		– Sell
-25,035
Closed -$787K – 9681
2016
Q1 		$686K Buy
+25,035
New +$737K ﹤0.01% 5833
2015
Q4 		– Sell
-33,422
Closed -$1.04M – 10251
2015
Q3 		$960K Buy
33,422
+5,774
+21% +$247K ﹤0.01% 5840
2015
Q2 		$1.24M Buy
27,648
+14,732
+114% +$554K ﹤0.01% 5744
2015
Q1 		$447K Sell
12,916
-24,919
-66% -$678K ﹤0.01% 7298
2014
Q4 		$1.04M Buy
+37,835
New +$918K ﹤0.01% 5807

Other funds holding DPLO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Susquehanna International Group's DPLO Position: Q1 2020 in Review

Susquehanna International Group sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 28,870 shares — an estimated $115K sold.

Susquehanna International Group first reported a position in DPLO in Q4 2014 and held it in 9 quarters. The position peaked at $1.24M in Q2 2015. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

  • Susquehanna International Group reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
  • Susquehanna International Group sold 28,870 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $115K.
  • Susquehanna International Group first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 9 quarters.
  • Susquehanna International Group's DIPLOMAT PHARMACY, INC. position peaked at $1.24M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Susquehanna International Group's 13F filing for Q1 2020, filed 15 May 2020.